Parabolic Drugs (Delisted) share news and announcements
BSE: 533211Pharmaceuticals & Biotechnology
Last traded ₹5.50 on 25 Jan 2021
Delisted on 11 Aug 2021.
Parabolic Drugs share news and announcements
677 announcements, routine notices left out, newest first. Page 4 of 14.
Jul 2018
19 Jul · Shareholding for the Period Ended June 30, 2018
Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....19 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 018 Jul · Board Meeting On 21/07/2018
Jun 2018
May 2018
31 May · Legal
Exchange has sought clarification from Parabolic Drugs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone Reconciliation of profit and loss not submitted -2. Standalone Reconciliation of Equity not submitted -3. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -4. Consolidated Reconciliation of profit and loss not submitted -5. Consolidated Reconciliation of Equity not submitted The response of the Company is awaited.30 May · Legal
Exchange has sought clarification from Parabolic Drugs Limited with respect to announcement dated 29-May-2018, regarding regarding Board meeting held on May 29, 2018.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.29 May · Board meeting
16 May · BOARD MEETING On 29-05-2018
Apr 2018
28 Apr · COMPLIANCE REPORT ON TRANSFER OR TRANSMISSION OR TRANSPOSITION OF SECURITIES FOR THE QUARTER/HALF YEAR ENDED ON 31St March, 2018 !
28 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements), 2015 !
24 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....21 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2018
19 Feb · Legal
Exchange has sought clarification from Parabolic Drugs Limited with respect to announcement dated 13-Feb-2018, regarding " Parabolic Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on February 13, 2018.This is to inform you that the Board of Directors in its Meeting held on 13th February, 2018 and concluded at 05:10 p.m. :1. Approved the Unaudited Financial Results of the Company for the Quarter ended on 31st December, 2017.2. This is to inform you that Mr. Ashok Kumar Jindal, Chief Financial Officer and Compliance Officer of the Company has resigned from the service of the Company to pursue future career objectives.3. The Company is in the process of appointing a Company Secretary who will act as the Compliance Officer of the Company. In the meantime, Mr. Pranav Gupta (Managing Director) shall act as Compliance Officer pursuant to the SEBI Listing Regulation.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment); The response of the Company is awaited.2 Feb · Board Meeting On 13-02-2018
Jan 2018
25 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....25 Jan · Compliance Certificate Pursuant To Regulation 13 Of SEBI (Listing Obligations And Disclosure Requirements), 2015 !
Dec 2017
20 Dec · Legal
Exchange has sought clarification from Parabolic Drugs Limited with respect to announcement dated 20-Dec-2017, regarding Outcome of Board Meeting held on December 20, 2017.This is to inform you that the Board of Directors in its Meeting held on 20th December, 2017 and concluded at 03:15 p.m. : 1. This is to inform you that Ms. Ishrat Gill, Company Secretary and Compliance Officer of the Company has resigned from the service of the Company to pursue future career objectives.1. Date of appointment/cessation (as applicable) & term of appointment;The response of the Company is awaited.13 Dec · Board Meeting On 20/12/2017
Nov 2017
15 Nov · Legal
Exchange has sought clarification from Parabolic Drugs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Reconciliation of profit and loss not submitted -2. Reconciliation of Equity not submitted The response of the Company is awaited.13 Nov · Board meeting
Oct 2017
23 Oct · Legal
23 Oct · Legal
The exchange asked on 23 Oct 2017